Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Johnson

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Virology|October 22, 2025
Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trialMatthew G Johnson, Julie M Strizki, David W Hilbert, et al.
Clinical and Translational Science|April 9, 2024
Molnupiravir: Mechanism of action, clinical, and translational scienceBrian M Maas, Julie Strizki, Randy R Miller, et al.
The Journal of Antimicrobial Chemotherapy|July 5, 2022
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trialDavid L Paterson, Matteo Bassetti, Mary Motyl, et al.
Mayo Clinic Proceedings|April 4, 2012
Service census caps and unit-based admissions: resident workload, conference attendance, duty hour compliance, and patient safetyUma Thanarajasingam, Furman S McDonald, Andrew J Halvorsen, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|January 10, 2014
Evaluating implementation of a rapid response team: considering alternative outcome measuresJames P Moriarty, Nicola E Schiebel, Matthew G Johnson, et al.
Health Services Research|June 16, 2015
Incorporating the Last Four Digits of Social Security Numbers Substantially Improves Linking Patient Data from De-identified Hospital Claims DatabasesJames M Naessens, Sue L Visscher, Stephanie M Peterson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 20, 2022
A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infectionsYihong Sun, Jia Fan, Gang Chen, et al.
The Pediatric Infectious Disease Journal|August 29, 2018
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative InfectionJohn S Bradley, Jocelyn Y Ang, Antonio C Arrieta, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Implementation of Bar-Code Medication Administration to Reduce Patient HarmKristine M Thompson, Kristi M Swanson, Debra L Cox, et al.
Journal of Primary Care & Community Health|November 4, 2022
Key Stakeholder Perspectives of Community Engagement Efforts and the Impact of the Covid-19 PandemicLily Huang, Tiera Cleveland, Kristin Clift, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Virology|October 22, 2025
Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trialMatthew G Johnson, Julie M Strizki, David W Hilbert, et al.
Clinical and Translational Science|April 9, 2024
Molnupiravir: Mechanism of action, clinical, and translational scienceBrian M Maas, Julie Strizki, Randy R Miller, et al.
The Journal of Antimicrobial Chemotherapy|July 5, 2022
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trialDavid L Paterson, Matteo Bassetti, Mary Motyl, et al.
Mayo Clinic Proceedings|April 4, 2012
Service census caps and unit-based admissions: resident workload, conference attendance, duty hour compliance, and patient safetyUma Thanarajasingam, Furman S McDonald, Andrew J Halvorsen, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|January 10, 2014
Evaluating implementation of a rapid response team: considering alternative outcome measuresJames P Moriarty, Nicola E Schiebel, Matthew G Johnson, et al.
Health Services Research|June 16, 2015
Incorporating the Last Four Digits of Social Security Numbers Substantially Improves Linking Patient Data from De-identified Hospital Claims DatabasesJames M Naessens, Sue L Visscher, Stephanie M Peterson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 20, 2022
A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infectionsYihong Sun, Jia Fan, Gang Chen, et al.
The Pediatric Infectious Disease Journal|August 29, 2018
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative InfectionJohn S Bradley, Jocelyn Y Ang, Antonio C Arrieta, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Implementation of Bar-Code Medication Administration to Reduce Patient HarmKristine M Thompson, Kristi M Swanson, Debra L Cox, et al.
Journal of Primary Care & Community Health|November 4, 2022
Key Stakeholder Perspectives of Community Engagement Efforts and the Impact of the Covid-19 PandemicLily Huang, Tiera Cleveland, Kristin Clift, et al.
Pageof 11